| Financial Year |
March 31 2023 |
| Monetary Funds |
679,799,858.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,248,287.59 |
| Accounts Receivable |
653,832,293.38 |
| Advances to Suppliers |
21,269,614.14 |
| Other Receivables |
55,509,620.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
612,375.00 |
| Dividend Receivable |
-- |
| Inventories |
449,435,700.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,537,243.77 |
| Total Current Assets |
1,880,817,301.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
319,983,488.19 |
| Long-term Equity Investment |
43,083,796.70 |
| Investment Properties |
529,321,445.54 |
| Fixed Assetes |
186,587,470.12 |
| Under-construction Projects |
7,676,802.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
299,689,403.59 |
| R&D expenses |
16,279,803.80 |
| Goodwill |
36,777,361.92 |
| Long-Term Deferred and Prepaid Expenses |
62,830,477.95 |
| Deferred Income Tax Assets |
40,149,347.77 |
| Other Non-Current Assets |
22,371,162.28 |
| Sub-Total of Non-Current Assets |
1,792,314,317.99 |
| Total Assets |
3,673,131,619.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
148,443,993.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,691,893.77 |
| Taxes Payable |
47,029,525.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
239,518,951.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
99,330,053.87 |
| Other Current Liabilities |
24,289,728.83 |
| Sub-Total of Current Liabilities |
739,665,976.65 |
| Long-term Loans |
300,255,473.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
481,943,847.94 |
| Total Liabilities |
1,221,609,824.59 |
| Paid-In Capital(Or Share Stock) |
649,298,541.00 |
| Capital Surplus |
1,008,408,403.95 |
| Surplus Reserve |
155,485,520.91 |
| LESS:Treasury Stock |
29,467,252.00 |
| Undistributed Profits |
560,846,579.54 |
| Minority Stockholder's Interest |
106,950,001.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,344,571,793.40 |
| Owner's Equity（Stockholder's Equity） |
2,451,521,795.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,673,131,619.70 |
